glp-1 therapy for diabetes Beyond Blood Glucose: How GLP-1s are Changing Management A clinician's perspective 📝 GLP-1

A study published in Annals of Internal Medicine examined how glucagon-like peptide-1 receptor agonists (GLP-1RAs, also known as GLP-1 drugs), sold under brand names such as Ozempic, affected depression risk compared to two other medications used in diabetes treatment

Understanding how the drug works, its benefits, and its side effects is important before starting treatment

Trends In FDA FY 2025 Warning Letters By Erin Hartmann and Liz Oestreich, ELIQUENT Life Sciences The U.S

Two advanced injectable medications Mounjaro and Ozempic have shown significant benefits for both blood sugar control and weight management